regulatory elements in human multipotent hematopoietic progenitors High-definition mapping of retroviral integration sites identifies active

doi:10.1182/blood-2010-05-283523Prepublished online September 23, 2010;2010 116: 5507-5517€€€€Fulvio MavilioDaniela Sartori, Alessandro Guffanti, Clelia Di Serio, Alessandro Ambrosi, Gianluca De Bellis and Claudia Cattoglio, Danilo Pellin, Ermanno Rizzi, Giulietta Maruggi, Giorgio Corti, Francesca Miselli,€

[1]  Jérôme Larghero,et al.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.

[2]  R. Childs,et al.  Ex vivo expansion of retrovirally transduced primate CD34+ cells results in overrepresentation of clones with MDS1/EVI1 insertion sites in the myeloid lineage after transplantation. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Nicola K. Wilson,et al.  Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation , 2010, Nucleic acids research.

[4]  G. Kreiman,et al.  Widespread transcription at neuronal activity-regulated enhancers , 2010, Nature.

[5]  Alessandro Aiuti,et al.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency. , 2009, The New England journal of medicine.

[6]  David Haussler,et al.  The UCSC Genome Browser database: update 2010 , 2009, Nucleic Acids Res..

[7]  Nicola K. Wilson,et al.  Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors. , 2009, Blood.

[8]  Mark A. Dawson,et al.  The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. , 2009, Blood.

[9]  A. Schambach,et al.  Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  S. Levy,et al.  NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation. , 2009, Developmental cell.

[11]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[12]  Davide Cittaro,et al.  Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome , 2009, PloS one.

[13]  Dustin E. Schones,et al.  Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. , 2009, Cell stem cell.

[14]  Davide Cittaro,et al.  CARPET: a web-based package for the analysis of ChIP-chip and expression tiling data , 2008, Bioinform..

[15]  R. Young,et al.  H2AZ Is Enriched at Polycomb Complex Target Genes in ES Cells and Is Necessary for Lineage Commitment , 2008, Cell.

[16]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[17]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[18]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[19]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[20]  P. Park,et al.  Differential H3K4 methylation identifies developmentally poised hematopoietic genes. , 2008, Developmental cell.

[21]  A. Engelman,et al.  The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication , 2008, PLoS pathogens.

[22]  C. Dunbar,et al.  The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  O. Kirak,et al.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 , 2008, Nature.

[24]  Jim Stalker,et al.  A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci , 2008, PLoS biology.

[25]  Caroline L. Speck,et al.  Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. , 2007, Blood.

[26]  Doron Lancet,et al.  Novel definition files for human GeneChips based on GeneAnnot , 2007, BMC Bioinformatics.

[27]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[28]  Alessandro Aiuti,et al.  Hot spots of retroviral integration in human CD34+ hematopoietic cells. , 2007, Blood.

[29]  Luca Biasco,et al.  Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. , 2007, The Journal of clinical investigation.

[30]  Su Yeon Kim,et al.  Adaptive Evolution of Conserved Noncoding Elements in Mammals , 2007, PLoS genetics.

[31]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[32]  Yoko Fukuda,et al.  An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling , 2007, Cell.

[33]  F. J. Novo,et al.  TICdb: a collection of gene-mapped translocation breakpoints in cancer , 2007, BMC Genomics.

[34]  Alan M. Moses,et al.  In vivo enhancer analysis of human conserved non-coding sequences , 2006, Nature.

[35]  Paul Shinn,et al.  Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection , 2006, PLoS pathogens.

[36]  Clelia Di Serio,et al.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration , 2006, Nature Biotechnology.

[37]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[38]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.

[39]  C. Chiang,et al.  The General Transcription Machinery and General Cofactors , 2006, Critical reviews in biochemistry and molecular biology.

[40]  Alessandro Fatica,et al.  A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.

[41]  Shyam Prabhakar,et al.  Close sequence comparisons are sufficient to identify human cis-regulatory elements. , 2005, Genome research.

[42]  Sridhar Hannenhalli,et al.  Genome-wide analysis of retroviral DNA integration , 2005, Nature Reviews Microbiology.

[43]  K. Akashi,et al.  Distal elements are critical for human CD34 expression in vivo. , 2002, Blood.

[44]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[45]  A. Fischer,et al.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.

[46]  M. Hattori,et al.  Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. , 2001, Gene.

[47]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.